MedTrace Logo

Evaluation of Guided Tissue Regeneration With Autogenous Bone Chips and CGF During Implant Placement

NCT07521514 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 8

Last updated 2026-04-13

No results posted yet for this study

Summary

CGF membranes will be prepared using a swing-lock centrifuge. A full-thickness mucoperiosteal flap will be elevated in a narrow alveolar ridge. Implants will be inserted. Autologous bone chips will be harvested via bone scraping and used for augmentation, CGF membranes will be placed over the grafted area. Suturing of the mucoperiosteal flap. Radiographic evaluation of the bone density and tissue thickness will be performed by CBCT preoperatively, immediate postoperative and after the procedure by 4 months. Clinical evaluation of the tissue thickness using periodontal probe preoperatively, immediate postoperatively and after the procedure by 4 months

Conditions

  • Alveolar Bone Loss
  • Alveolar Ridge Augmentation
  • Dental Implant

Interventions

OTHER

concentrated growth factor (CGF) Membrane

This is a third-generation autologous blood concentrate prepared using a dedicated centrifuge system. The process creates a fibrin-rich organic matrix from the patient's own blood, which is then molded into a membrane and packed over the grafted bone to enhance bone density increase and improvement of the surrounding tissue.

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Hesham Elsayed Elhawary, Professor · Cairo University

  • Abdelmoez Mohamed El-Sharkawy, Assistant Professor · Cairo University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-04-16
Primary Completion
2026-09-30
Completion
2026-10-31

Countries

  • Egypt

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07521514 on ClinicalTrials.gov